检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:卢冲[1] 吴姗姗[1] 刘永丹[1] 殷萍[1] 魏亚芬[1]
出 处:《中国药物经济学》2016年第8期32-34,共3页China Journal of Pharmaceutical Economics
摘 要:目的探讨氟哌噻吨美利曲辛片与尼莫地平治疗偏头痛患者的临床效果。方法选取2014年1月至2015年6月黑龙江省医院神经内科收治的82例偏头痛患者作为研究对象,按照随机数字表法将其分为A组与B组,每组41例。A组患者采用氟哌噻吨美利曲辛片进行治疗,B组患者给予尼莫地平片,比较两组患者临床疗效、治疗前后头痛症状改善情况及不良反应发生情况。结果 A组患者治疗的总有效率明显高于B组,差异有统计学意义(P<0.05);治疗后,A组患者的头痛发作次数、疼痛视觉模拟量表(VAS)评分均显著低于B组,持续时间明显短于B组,差异均有统计学意义(均P<0.05)。结论氟哌噻吨美利曲辛片用于治疗偏头痛的疗效显著优于尼莫地平,能够有效改善患者症状,且不良反应较少,是一种相对安全有效的药物。Objective To investigate the clinical effects of Flupentixol and Melitracen Tablets and nimodipine in the treatment of patients with migraine.Methods Select 82 patients with migraine as the research object in the Department of internal medicine,Heilongjiang Hospital from January 2014 to June 2015,according to the random number table method is divided into A group and B group,each group of 41 cases.A group of patients with droperidol thiadiazole melitracen tablets for treatment,the patients in the group B were given nimodipine tablets,compared two groups of patients with clinical curative effect,before and after the treatment of headache symptoms and adverse reaction incidence. Results Patients in group A were treated total efficiency was significantly higher than that of group B,the difference is statistically significant(P0.05).After the treatment,a group of patients with headache attack frequency,pain visual analogue scale(VAS) scores were significantly lower than that of group B,duration was significantly shorter than that in group B,there were statistically significant difference(P〈0.05).Conclusion Droperidol Flupentixol and melitracen tablets for migraine treatment curative effect was better than that of nimodipine,can effectively improve the symptomsof the patients,and fewer adverse reactions, is a relatively safe and effective drug.
分 类 号:R747.2[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3